Several 2026 papers mention both fenbendazole and cancer, ranging from reviews and oncology-focused discussions to case reports and translational/nanomedicine papers.
The strongest direct match is a Journal of Clinical Oncology abstract on real-world fenbendazole use among cancer patients, along with multiple cancer-oriented papers describing fenbendazole as having anticancer potential or used in cancer-related nanocarrier strategies.
Bottom line
Yes—2026 includes multiple papers that mention fenbendazole, including a cautionary clinical paper stating that efficacy is not supported by rigorous trials. That means the topic is in the literature, but mostly as repurposing interest, drug-delivery work, or usage-pattern reporting, not as established evidence for cancer treatment yet.
References
Olutayo, E., Phan, M.V., Willis, J., Hu, Z.I. (2026) A single institutional experience on patterns of ivermectin and fenbendazole use among patients with gastrointestinal cancers.. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2026.44.2_suppl.818
Khan, I., Ali, M.S., Karim, S., (...), Kesharwani, P. (2026) Engineered PLGA Nanocarriers advance precision drug delivery in ovarian Cancer. Inorganic Chemistry Communications. https://doi.org/10.1016/j.inoche.2026.117059
Zheng, H., Yuan, Y., Zhang, X., (...), Li, X. (2026) Localized nanomedicine for urologic cancers: anatomy-guided design and clinical translation. Materials Today Bio. https://doi.org/10.1016/j.mtbio.2026.103740
Alomari, M.I., Ababneh, T.S., Dawoud, J.N., (...), Shammout, M.J.A. (2026) Computational insights into fenbendazole encapsulation by Cucurbit[n]urils (n = 7, 8): Implications for drug delivery and nanocarrier design through integrated structural, electronic, thermodynamic, and spectroscopic investigations. Journal of Molecular Graphics and Modelling. https://doi.org/10.1016/j.jmgm.2026.109410